Disclaimer: This article was published in 2021 and reflects the information available at that time.
  The PDL Professional Officers have noted a recent reduction in the number of calls about the COVID-19 vaccination service. This is pleasing and a likely indication of reduced demands on pharmacists and a greater familiarity with the vaccination process. However, this phase of the pharmacy vaccination service brings other challenges. With the inclusion of the Pfizer Comirnaty vaccine into the pharmacy vaccination program, there are increased risks that need to be identified and managed by pharmacists and pharmacy owners. Managing three brands of vaccine Handling three different v…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

New NSW medicines and poisons legislation now in effect
10 November 2026
NSWProfessional activitiesRegulatory and compliancePractice support, tips and tools
Learn more
The myth of the owing prescription
15 October 2026
NationalDispensingRegulatory and compliancePractice support, tips and tools
Learn more
Is this the right jab? RSV vaccine selection reminder
25 August 2026
NationalDispensingProfessional activitiesVaccinationRegulatory and compliancePractice support, tips and tools
Learn more